Epigenomics AG Stock Xetra
Equities
DE000A1K0516
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.44M 1.55M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | - 0 | EV / Sales 2024 * | - |
Net cash position 2024 * | 2.48M 2.67M | Net cash position 2025 * | 1.39M 1.49M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.84
x | P/E ratio 2025 * |
-2.87
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.77% |
1st Jan change | Capi. | |
---|---|---|
-27.67% | 9.96B | |
+34.87% | 3.76B | |
-17.30% | 2.37B | |
-11.15% | 2.27B | |
-22.32% | 1.58B | |
+59.69% | 1.31B | |
-1.31% | 750M | |
+23.58% | 575M | |
-28.57% | 525M |